|
HerbalEGram: Volume 7, Number 11, November 2010
NCCAM Prioritizes Several Herbs for Mechanistic Research Grant
|
The National Center for Complementary and Alternative
Medicine (NCCAM) of the US National Institutes of Health (NIH) has designated
several herbs as funding priorities for a recent $8.1 million grant project.1 “Mechanistic Research on CAM Natural
Products” is sponsored by NCCAM, the National Cancer Institute (NCI), and the
Office of Dietary Supplements (ODS).2 It funds only research on the action
mechanisms of natural products, so studies on products’ clinical efficacy will
not be funded by this particular project. Acceptance of applications began
November 1, 2010. (More information on the grant and its various due dates is
available here.)
While the investigation of herbs’ and other CAM products’
efficacy is essential and ongoing at NCCAM, understanding how the substances
work in humans to produce specific outcomes is also important.2
And, according to NIH’s grant announcement, “Despite
the widespread use of these products, insight into potential biological
mechanisms of action frequently is lacking.” Additionally, the composition of many
natural products, botanicals especially, is complex and makes understanding
their action mechanisms significantly more difficult.
NCCAM has listed the following herbs as areas of priority in
regards to the mechanistic research grant project.1
Below are more details on what types of research NCCAM is focusing on funding
with the grant.
- Ashwagandha
(Withania somnifera)
- Astragalus
(Astragalus membranaceus)
- Devil's
claw (Harpagophytum procumbens)
- Echinacea
(Echinacea purpurea)
- Ginseng,
Asian & American (Panax ginseng,
P. quinquefolius)
- Hops (Humulus
lupulus)
- Milk
thistle (Silybum marianum)
- Thunder god vine (Tripterygium
wilfordii)
- Turmeric
(Curcuma longa)
More
specifically, NCCAM will focus on funding ashwagandha research that
investigates whether a more systemic type of activity is responsible for the
herb’s diverse effects on the body, which include anti-leishmanial activity,
immune modulation, decreased anxiety, and possible prevention of
neurodegenerative diseases and cancer. Accepted research might examine such
physical responses to the herb as changes in gene, protein, or regulatory RNA
expression or localization.
Though
recent research has identified several active components of astragalus, NCCAM
would like to fund research that aims to “fully characterize the bioactive
compounds” of this herb and its activities and mechanisms of action,
particularly looking at complex polysaccharides.
Research
on devil’s claw funded by this particular NCCAM grant would, in part, aim to identify a biomarker of anti-inflammatory activity (other than the
harpagoside compound), as well as study the herb’s documented analgesic
properties, analgesic mechanisms of action, and the compounds responsible for
these effects.
Because
some in vitro activity of echinacea has
depended on the plant part and extraction method used, funded studies would
seek to identify both optimal species and extraction methods. Also, research
would focus on identifying components responsible for immune activities and
marker components for standardization and pharmacokinetics, and clarifying the
biological signature.
As for ginseng research, NCCAM is encouraging investigations
using systems biology approaches to study the potential action mechanisms of
specific components, such as individual ginsenosides and ginseng-derived
glycans or terpenoids from different ginseng species or preparations.
Prioritized hops research would seek to establish better
understanding of its phytoestrogenic principles, including receptor or tissue
specificity, and which components are responsible for any sedative activity and
their action mechanisms.
Further, NCCAM will focus on funding milk thistle research
that investigates the in vitro and in
vivo activity of the plant’s individual
components and how the components work collectively, as well as studies into
mechanisms associated with the hepatoprotective and chemopreventive activities
and the herb/drug interactions of silymarin, an extract of milk thistle.
Thunder god vine research that receives NCCAM funding from
this particular grant would focus on identifying compounds other than
triptolide that might influence the plant’s overall activity. Lastly, turmeric
studies would investigate the metabolites responsible for activity and their
tissue distribution, pharmacokinetics, and pharmacodynamics, as well as the
bioavailability of individual curcuminoids compared with different formulations
of mixtures and extracts.
Additional CAM areas of interest for the mechanistic action
grant project include beta-glucans, coenzyme Q 10, polyphenols (e.g.,
flavonoids, catechins, anthocyanins), probiotics, polyunsaturated fatty acids
(PUFAs), and vitamin D. According to NCCAM, this listing of research priority
areas is not exhaustive and might change over time as new science emerges and
brings with it new priorities. More detailed information on these research
priorities, as well as examples of responsive projects funded by this grant is
available here.
—Lindsay Stafford
References
1. NCCAM high-priority topics for mechanistic research on CAM natural products
(R01) RFA-AT-11-001. National Center for Complementary and Alternative Medicine
website. Available at: www.nccam.nih.gov/grants/CAMNP/priorities/?nav=upd.
Accessed October 28, 2010.
|
|